Vedolizumab for treating moderate to severe active Crohn's disease after prior therapy [ID690]
Rafia R, Scope A, Harnan S, Stevens JW, Stevenson M, Sutton A, Dickinson K, Parkes M, Mayberry J, Lobo A
Record ID 32015000758
English
Details
Project Status:
Completed
URL for project:
http://www.nets.nihr.ac.uk/projects/hta/1312801
Year Published:
2014
URL for published report:
http://www.nets.nihr.ac.uk/projects/hta/1312801
URL for additional information:
http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0018/133650/ERGReport-13-128-01.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Antibodies, Monoclonal, Humanized
- Anti-Inflammatory Agents
- Treatment Failure
- Remission Induction
- Glucocorticoids
- Immunosuppressive Agents
- Colitis, Ulcerative
- Crohn Disease
- Gastrointestinal Agents
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.